Promises of natural products as clinical applications for cancer
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-02 · 1880 (1) · 189241
DOI: 10.1016/j.bbcan.2024.189241 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-02. Verfasst von Rui Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Phytogenic, Neoplasms, Biological Products. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 125 Literaturangaben.
Abstract (Originalsprache)
Cancer represents a substantial threat to human health and mortality, necessitating the development of novel pharmacological agents with innovative mechanisms of action. Consequently, extensive research has been directed toward discovering new anticancer compounds derived from natural sources, including plants, microbes, and marine organisms. This review offers a comprehensive analysis of natural anticancer agents that are either currently undergoing clinical trials or have been integrated into clinical practice. A comprehensive understanding of the historical origins of natural anticancer agents, alongside traditional targets for tumor treatment and the distinct characteristics of cancer, can significantly facilitate researchers in the discovery and development of innovative anticancer drugs for clinical use. Furthermore, the exploration of microbial and marine sources is currently a prominent area of focus in the clinical application and advancement of new anticancer therapies. Detailed classification and elucidation of the functions and antitumor properties of these natural products are essential. It is imperative to comprehensively summarize and comprehend the natural anticancer drugs that have been and continue to be utilized in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023. China; Nanjing Integrated Traditional Chinese And West…
- Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023. China; Jiangsu Joint International Research Laboratory…
- Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023. China.
Zitieren
APA
Deng, R., Zong, G. F., Wang, X., Yue, B. J., Cheng, P., Tao, R. Z., Li, X., Wei, Z. H., & Lu, Y. (2025). Promises of natural products as clinical applications for cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(1), 189241. https://doi.org/10.1016/j.bbcan.2024.189241
Vancouver
Deng R, Zong GF, Wang X, Yue BJ, Cheng P, Tao RZ, et al. Promises of natural products as clinical applications for cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(1):189241. doi:10.1016/j.bbcan.2024.189241
BibTeX
@article{Deng2025,
author = {Deng, Rui and Zong, Gang-Fan and Wang, Xi and Yue, Bing-Jie and Cheng, Peng and Tao, Rui-Zhi and Li, Xiaoman and Wei, Zhong-Hong and Lu, Yin},
title = {Promises of natural products as clinical applications for cancer},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {1},
pages = {189241},
doi = {10.1016/j.bbcan.2024.189241}
}
EUVIMED